LY-2608204

DB12284InvestigationalSmall molecule

LY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.

Chemical structure of LY-2608204
Mechanism
Curator reviewed
Formula / weight
C28H37N3O3S3 · 559.8 g/mol (avg)
Code names
LY2608204

Resolves to

Compound
UNII5A0L003HEYCAS1234703-40-2PubChem46832368
Structure
InChIKeyQIIVJLHCZUTGSD-CUBQBAPOSA-NSMILESO=C(NC1=NC=C(SCCN2CCCC2)S1)[C@@]1(C[C@H]1C1CCCCC1)C1=CC=C(C=C1)S(=O)(=O)C1CC1
Targets
P35557GCKO14757CHEK1

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with LY-2608204, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In